In breast cancer, PPP2R2B expression was strongly associated with immune check point inhibitor genes such as BZMA, PRF1, and IFNG, suggesting that downregulation of PPP2R2B could take part in tumor immune evasion [57]. This evidence concerns the gene PPP2R2B and neoplasm.